Clinical Trial Update: Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study assessing dovitinib with biomarkers in advanced non-small cell lung cancer and advanced colorectal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Dovitinib (dovitinib)

Snippet

Sponsor: University of California, Davis | Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-15